Regencell Bioscience Holdings Limited Cash and Restricted Cash
Regencell Bioscience Holdings Limited (RGC) had Cash and Restricted Cash of $2.42 million as of 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-10-31
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.42M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.96M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.56M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.42M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-06-30 | $2.42M 20-F · filed 2025-10-31 |
| 2024-06-30 | $2.96M 20-F · filed 2025-10-31 |
| 2023-06-30 | $1.56M 20-F · filed 2025-10-31 |
| 2022-06-30 | $6.42M 20-F · filed 2025-10-31 |
| 2021-06-30 | $59.41K 20-F · filed 2024-10-25 |
| 2020-06-30 | $386.98K 20-F · filed 2023-10-27 |
| 2019-06-30 | $243.31K 20-F · filed 2022-10-31 |